Recipharm will publish its interim report for January-June 2016 on 22 July at 07:45 am CET. The company invites investors, analysts and media to a web conference (in English) on 22 July at 10:00 am CET, where CEO Thomas Eldered and CFO Björn Westberg will present and comment on the report as well as answer questions. The report will be available on Recipharm’s website www.recipharm.com/investor -relations from 07:45 am CET the same day and the presentation from the webcast will be uploaded during the day on the 22 July. To participate in the web conference, please use the below link: http://edge.media-server.com/m/p/ufdsgyft Questions may be submitted by dialing below telephone numbers or by typing them in the Q&A box during the conference. If you don’t wish to ask questions by telephone you only need to participate through the link above. From Sweden: + 46 8 505 963 06 From Denmark: + 45 354 45597 From Finland: + 358 9 8171 0317 From France: + 33 29092 0977 From Germany: + 49 30 211 510 067 From India: + 91 226187 51 03 From Italy: + 39 2 3604 67 98 From Norway: + 47 235 00 559 From Portugal: + 35 210 609104 From Spain: + 34 911 143 608 From Switzerland: + 41 44 5800083 From the UK: + 44 203 139 48 30 From the USA: + 1 718 873 90 77 Pin code for participants: 44823539# For more information, please contact: Björn Westberg, CFO, +46 8 602 46 20, ir@recipharm.com Recipharm AB (publ) Corporate identity number 556498-8425 Address Lagervägen 7, SE-136 50 Jordbro, Sweden, Telephone 46 8 602 52 00, Fax 46 8 81 87 03 www.recipharm.com
Invitation to presentation of Recipharm’s interim report for the second quarter 2016 on the 22nd July
| Source: Recipharm AB